Juan Carlos
Galofre Ferrater
Consultor Médico
![Foto de Juan Carlos](/img/nophoto.png)
![Foto de Hospital Vall d'Hebron](/img/noimage_org.png)
Hospital Vall d'Hebron
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Hospital Vall d'Hebron (15)
2023
-
Co-occurrence of mutations in NF1 and other susceptibility genes in pheochromocytoma and paraganglioma
Frontiers in Endocrinology, Vol. 13
2022
-
Initial clinical and treatment patterns of advanced differentiated thyroid cancer: ERUDIT study
European Thyroid Journal, Vol. 11, Núm. 5
2021
-
Erratum: Late Recovery of Parathyroid Function after Total Thyroidectomy: A Case-Control Study (Horm Metab Res (2021) 53 DOI: 10.1055/a-1608-1373)
Hormone and Metabolic Research
-
Late Recovery of Parathyroid Function after Total Thyroidectomy: A Case-Control Study
Hormone and Metabolic Research, Vol. 53, Núm. 10, pp. 654-661
-
Recovery of parathyroid function in patients with thyroid cancer treated by total thyroidectomy: An analysis of 685 patients with hypoparathyroidism at discharge of surgery
Endocrinologia, Diabetes y Nutricion, Vol. 68, Núm. 6, pp. 398-407
2020
-
Permanent postoperative hypoparathyroidism: an analysis of prevalence and predictive factors for adequacy of control in a cohort of 260 patients
Gland Surgery, Vol. 9, Núm. 5, pp. 1380-1388
-
The extent of surgery for low-risk 1–4 cm papillary thyroid carcinoma: a catch-22 situation. A retrospective analysis of 497 patients based on the 2015 ATA Guidelines recommendation 35
Endocrine, Vol. 70, Núm. 3, pp. 538-543
-
Utilidad del test de TSH recombinante en el seguimiento de pacientes con cáncer diferenciado de tiroides según los resultados de tiroglobulina basal
Advances in Laboratory Medicine, Vol. 1, Núm. 1
-
Utility of recombinant human TSH stimulation test in the follow-up of patients with differentiated thyroid cancer depending on basal thyroglobulin results
Advances in Laboratory Medicine, Vol. 1, Núm. 1
2019
-
Correction to: Prevalence and risk factors for hypoparathyroidism following total thyroidectomy in Spain: a multicentric and nation-wide retrospective analysis (Endocrine, (2019), 66, 2, (405-415), 10.1007/s12020-019-02014-8)
Endocrine
-
Prevalence and risk factors for hypoparathyroidism following total thyroidectomy in Spain: a multicentric and nation-wide retrospective analysis
Endocrine, Vol. 66, Núm. 2, pp. 405-415
2017
-
PheoSeq: A Targeted Next-Generation Sequencing Assay for Pheochromocytoma and Paraganglioma Diagnostics
Journal of Molecular Diagnostics, Vol. 19, Núm. 4, pp. 575-588
2012
-
Comments to SEOM clinical guidelines for the treatment of thyroid cancer
Clinical and Translational Oncology
2011
-
Treatment of thyroid cancer with the new oral agents
Annals of Oncology
2009
-
Guía clínica para el diagnóstico y el tratamiento de la disfunción tiroidea subclínica en la gestación
Endocrinologia y Nutricion, Vol. 56, Núm. 2, pp. 85-91